Virtu KCG Holdings’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-156,400
Closed -$18.7M 4251
2015
Q4
$18.7M Buy
156,400
+65,600
+72% +$7.59M 0.32% 33
2015
Q3
$9.82M Buy
90,800
+28,700
+46% +$3.56M 0.16% 56
2015
Q2
$7.19M Buy
62,100
+5,500
+10% +$629K 0.13% 74
2015
Q1
$6.53M Buy
56,600
+6,700
+13% +$801K 0.13% 77
2014
Q4
$5.58M Sell
49,900
-22,100
-31% -$2.33M 0.09% 123
2014
Q3
$6.82M Sell
72,000
-74,300
-51% -$6.71M 0.13% 89
2014
Q2
$12.6M Sell
146,300
-46,700
-24% -$3.55M 0.2% 50
2014
Q1
$13.5M Sell
193,000
-76,000
-28% -$6.02M 0.17% 74
2013
Q4
$22.7M Buy
269,000
+72,800
+37% +$5.76M 0.25% 38
2013
Q3
$15.1M Buy
+196,200
New +$13.7M 0.19% 60

Other funds holding CELG

Virtu KCG Holdings's CELG Position: Q2 2017 in Review

Virtu KCG Holdings increased its Celgene Corp (CELG) stake by 116% in Q2 2017, buying an estimated $984K and bringing the position to 14,986 shares worth $1.95M. The position accounts for 0.05% of the portfolio, ranked #261.

Virtu KCG Holdings first reported a position in CELG in Q3 2013 and has held it in 16 quarters since. The position peaked at $10.7M in Q1 2014. 1,428 funds tracked by Wall St. Rank hold CELG as of Q2 2017.

  • Virtu KCG Holdings held 14,986 shares of Celgene Corp worth $1.95M as of Q2 2017.
  • Virtu KCG Holdings bought 8,034 Celgene Corp shares in Q2 2017, an estimated $984K.
  • Celgene Corp made up 0.05% of Virtu KCG Holdings's portfolio in Q2 2017, its #261 holding.
  • Virtu KCG Holdings first reported a position in Celgene Corp in Q3 2013 and has held it in 16 quarters since.
  • Virtu KCG Holdings's Celgene Corp position peaked at $10.7M in Q1 2014.
  • 1,428 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.